1. 10th Annual Pricing
and Reimbursement
Assessing the current landscape and exploring effective methods
to optimise return on investment
14th - 15th September 2011, Thistle City Barbican, London, UK BOOK NOW!
Key Speakers
Philippe Godfroid, Director, Head of Global Pricing & Reimbursement, GSK Biologicals
Anne-Toni Rodgers, Lead, Pricing & Market Access, AstraZeneca
Toros Sahin, P&R Coordinator, Sanofi-Aventis Turkey
Hervé Lilliu, Vice President Global Market Access, Health Outcomes & Pricing, UCB Pharma
Ulrich Reese, Partner, Clifford Chance
Nick Bosanquet, Professor of Health Policy, Imperial College
Leslie Galloway, Chairman, Ethical Medicines Industry Group
Andrew Lilico, Managing Director, Europe Economics
George Wyatt, Managing Director, Wyatt Health Management
Cyrus Chowdhury, Vice President, Global Market Access, Insight Strategy Advisors
Silver Sponsor Associate Sponsor
Organised By
Driving the Industry Forward | www.futurepharmaus.com
Media Partners
To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/pricing-and-reimbursement

2. Conference Introduction
10th Annual Pricing & Reimbursement
14th - 15th September 2011, London, UK
Dear Colleague, Silver Sponsor:
PriceSpective is a leading global value strategy consultancy,
ith the passing of the new Patient Protection and Affordable Care Act (2010)
W specializing in innovative strategies to define, drive and capture
in the US and increasing pressures in Europe by national healthcare authorities value for the biopharmaceutical industry. Using our unique
integrated approach we help our customers optimize pricing and
to lower pharmaceutical spending, worldwide pricing and reimbursement are market access strategies. We believe there is value in enhancing and prolonging human
set to become more stringent. It is now the case that countries like Germany life through the development and marketing of biopharmaceuticals. We guide our clients
and UK, which traditionally exert less control, plan to introduce value-based to develop products for patients with the most urgent medical unmet need or for diseases
with the highest economic burden. Through our work we help patients, healthcare systems
pricing. This trend is set to extend to emerging markets with governments and society and enable our clients to be justly rewarded for their efforts
vowing to curb healthcare spending. For further information please visit: www.pricespective.com
isiongain’s 10th Annual Pricing and Reimbursement Conference will address
V Associate Sponsor:
the latest international developments, provide detailed analysis of the pricing Inpharmation provide the pharmaceutical industry with an Evidence
market and enable you to gain better understanding of a product’s potential based approach to pricing. Our models are fully validated and are
based upon facts (what payers and prescribers do) as opposed to
price profile. opinions (what they or anyone else says they will do). Inpharmation models and techniques
are often unique, refreshingly simple and transparent without compromising accuracy. We
Why you should attend this conference can help you to price to the full value of your product and assess the price potential of
new assets in unfamiliar disease areas. Inpharmation has also developed industry leading
• Hear the latest in value based pricing technologies that allow us to fully model the interactions (parallel trade and international
price referencing) present in global pharmaceutical markets.
• Review the impact of the healthcare reform bill in the US For further information please visit: www.inpharmation.co.uk
• Discuss current developments in P & R policy in Canada, Turkey and Russia Media Partners:
PharmiWeb.com is the leading industry-sponsored portal for
• Explore risk-sharing pricing schemes across Europe the pharmaceutical sector. Supported by most of the leading
pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features,
• Evaluate the influence of parallel trade on drug pricing events listings and international jobs to industry professionals across Europe and the US.
• Analyse the effects of generic drugs use For further information please email: corporate@pharmiweb.com
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD.
• Examine the future of global pricing and reimbursement It is based and located in Warsaw, Poland. Biotechnology World
was founded in 2007 to provide the world’s biotech and pharma information and market
• Use this platform to stay ahead in this ever evolving sector to make it universally accessible and useful for scientific and business processes. Its first
step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will
I look forward to meeting you at the conference allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers
Best regards companies completed internet public relations, publication and marketing solutions. One of
the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector
in Europe to global biotechnology, pharmaceutical and life science activities.
For further information please visit: www.biotechnology-europe.com
Driving the Industry Forward | www.futurepharmaus.com
Future Pharmaceuticals has forged powerful relationships
Sumita Sengupta with key industry leaders to provide a platform for successful
brand recognition, and for senior decision-makers to have the means to procure and
Conference Producer plan implementation strategies based on the topics covered. Positioned to be an
authoritative resource within top pharma companies as well as small, specialty, and
biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into
a highly targeted and responsive audience, bridging the gap between the industries’
top issues and the solutions top-tier vendors can provide.
Who should attend? For further information please visit: www.futurepharmaus.com
InPharm is the online platform for exclusive pharmaceutical
Chief Executives, Vice Presidents, Directors, Heads and Managers of: news, comment, contracts, services, jobs and events and is
home to InPharmjobs.com, Pharmafile and Pharmafocus.
• Pricing and Reimbursement
For further information please visit: www.inpharm.com
• Market Access
• Strategic Pricing
Poster Presentation
• Price Monitoring At a busy conference it is hard to make sure everyone who shares your interests knows what you are
doing. Maximise your time at Visiongain’s 10th Annual Pricing & Reimbursement meeting by sharing
• Health Economics your results in a poster presentation. With a plethora of key decision makers, take advantage of this
senior networking opportunity.
• Commercial Pricing
Please send your 200 word abstract, in English, to: info@visiongainglobal.com for approval.
• Economics and Government Affairs The deadline for submissions is Thursday 1st September, 2011. Please include contact details for the
corresponding author(s).
• International Trade and Market Policy Academic institutions will not be charged a fee if booked as full-price delegates. Posters submitted by
pharmaceutical and biotechnology firms will be charged a fee of £199. Posters submitted by service
• Parallel Trade providers / vendors are welcome and will be subject to evaluation. Upon approval a fee of £500 will
apply. Two delegates from your organisation must be booked at full price to present a poster.
• Research and Development Please note that all posters will be displayed at the discretion of Visiongain Ltd and are subject to
approval. Due to limited space, please register your interest early.
• Business Strategy
• Sales & Marketing
Sponsorship and exhibition opportunities
• Brand Management This event offers a unique opportunity to meet and do business with some of the key players in
the pharmaceutical and biotech industries. If you have a service or product to promote, you can
• Corporate Strategy do so at this event by:
• Hosting a networking drinks reception
• Operations • Taking an exhibition space at the conference
• Legal & Regulatory Affairs • Advertising in the delegate documentation pack
• Providing branded bags, pens, gifts, etc.
• Health & Healthcare Policy If you would like more information on the range of sponsorship or exhibition possibilities for
visiongain's 10th Annual Pricing & Reimbursement Conference, please contact us:
• Outcomes Research Damian Gorman, +44 (0)20 7549 9934
damian.gorman@visiongainglobal.com

3. Day 1
10th Annual Pricing & Reimbursement
Wednesday 14th September 2011
09:00 Registration and refreshments 13:40 Pricing and reimbursement in Canada
• Pricing Regulation and Patented Medicine Prices Review Board (PMPRB)
09:30 Opening address from the Chair • ew strategies for the Canadian Agency for Drugs and Technologies in
N
Health (CADTH)
Hervé Lilliu
Vice President Global Market Access, Health Outcomes & Pricing • Reimbursement – public and private markets in Canada
UCB Pharma George Wyatt
Managing Director
Wyatt Health Management
09:40 Valued based pricing: UK perspective
• Review of the objectives of a VBP system 14:20 Russian localisation: access and pricing opportunities
• Experiences from the existing VBP mechanisms in the UK • Participating in the expansion of the Russian market
• Maximising your return on investment for market access
• Global mechanisms for VBP that exist, currently in other countries
• Improve your overall commercial success in Russia?
Adrian Towse
Director Cyrus Chowdhury
Office of Health Economics Vice President, Global Market Access
Insight Strategy Advisors
10:20 Value based pricing 15:00 Payer engagement and launch price planning
• Outline of proposed system – consequences of recent environmental events
• Key elements of the model • hat are payers looking for in a new product and what evidence
W
do they require?
• How the system might operate
• ow have the recent changes in some countries altered how we engage
H
• Industry perspective with payers at launch?
Leslie Galloway • hat are the elements of a launch price plan that we must consider to
W
Chairman be successful?
Ethical Medicines Industry Group (EMIG) • hat timelines are critical to the successful market access for our products?
W
Keiron Sparrowhawk
11:00 Morning refreshments Partner
PriceSpective
11:20 Market access in Germany after the Healthcare 15:20 Afternoon refreshments
Reform Act - moving towards a fourth hurdle?
• How to design the value dossier 15:40 A patient-centric approach to HTA
• Strategic implications for the pharmaceutical industry • How to develop a patient-centric value proposition
• The role of patient-reported outcomes and health economics
• Legal remedies and judicial review
• The right drug for the right patient at the right price
Ulrich Reese
Partner Hervé Lilliu
Clifford Chance Vice President Global Market Access, Health Outcomes & Pricing
UCB Pharma
12:00 Pricing and reimbursement in Turkey 16:20 Presentation to be announced
• Overview of Turkish Healthcare Environment Donald Macarthur
Global Pharmaceutical Business Analyst
• Turkish pricing system
Justpharmareports
• Turkish reimbursement system
• Future challenges for market access in Turkey 17:00 Closing remarks from the Chair
Toros Sahin
Pricing and Reimbursement Coordinator
Sanofi-Aventis Turkey 17:10 Networking drinks
Take your discussions further and build new
12:40 Networking lunch relationships in a relaxed and informal setting
Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011

4. Day 2
10th Annual Pricing & Reimbursement
Thursday 15th September 2011
09:00 Registration and refreshments 13:40 Accessibility to vaccines in the world today
• Accessibility strategy targets
09:30 Opening address from the Chair
• Accessibility levers
Cyrus Chowdhury
Vice President, Global Market Access • Tiered pricing models
Insight Strategy Advisors • Usage of tiered pricing
• Key challenges
09:40 Pricing & reimbursement in a changing healthcare
• Example of current initiative of accessibility
environment
Philippe Godfroid
Fabian Schmidt
Director, Head of Global Pricing & Reimbursement
Director General
GSK Biologicals
Simon Kucher & Partners
10:20 European centralisation of HTA; pricing and value 14:20 Pathway mapping and clinical audit-critical
• The myths and reality of centralisation processes for pharmaceutical reimbursement
• Current EU Policy and Projects • athway mapping in healthcare- relevance to pharma and
P
healthcare providers
• What orphan diseases can teach us
- Opportunities to bridge the provider/commissioner gap
• Future thinking: be ahead of the game
• Clinical auditing- the policy context
Anne-Toni Rodgers
Lead, Pricing & Market Access - Supporting the value proposition and reimbursement
AstraZeneca
15:00 Afternoon refreshments
11:00 Morning refreshments
11:20 HTA or reference pricing: Latin American 15:20 How do we score pricing and reimbursement goals
market access revolutions when the goalposts keep moving?
• Latin America- from decentralisation to regionalisation • Predicting when the pricing system is in flux (e.g. Germany, UK, Spain)
• razil’s pricing leadership position in the region and influence
B • redicting when the pricing system is cyclical (e.g. US formulary ‘openness’)
P
on other markets • Predicting when the next shoe drops (e.g. the next enforced price cut)
• an pharmaceutical MNCs shape pricing policies in
C Gary Johnson
Latin American markets? Managing Director
Inpharmation
Monica Martin de Bustamante
Principal, Global Market Access
Insight Strategy Advisors 16:00 Risk-sharing pricing schemes in the NHS and
elsewhere in Europe
12:00 How can pharma companies become legendary
Andrew Lilico
for value?
Managing Director
• Opportunities for presenting improved outcomes Europe Economics
• Pharma and new models of health care
• Health economics for innovators--not regulators 16:40 Chair’s closing remarks
• The differential outlook for pharma Europe/US/Asia
16:50 End of conference
Professor Nick Bosanquet
Head of Health Policy
Imperial College, London
12:40 Networking lunch

5. Registration Form
10th Annual Pricing & Reimbursement
14th - 15th September 2011, London, UK
Conf. code PP
10th Annual Pricing &
Standard Prices
Reimbursement 2011
Conference only Fee: £1299 VAT: £259.80 Total: £1558.80
14th - 15th September 2011
Number of bookings: Total cost: Location: Thistle City Barbican
Address:
Central Street, Clerkenwell
Promotional Literature Distribution London
Distribution of your company’s promotional literature to all conference attendees EC1V 8DS
UK
Fee: £999 VAT: £199.80 Total: £1198.80
Details How to book
Forename: Surname: Email: Piyush.patel@visiongainglobal.com
Web: http://www.visiongain.com/pricing-and-reimbursement
Job Title: Company: UK Office:
Tel: +44 (0) 20 7549 9961
Fax: +44(0) 20 7549 9932
Main Switchboard Number:
Visiongain Ltd
230 City Road
Address: London
EC1V 2QY
UK
General information
Country: Postcode: Venue: Thistle City Barbican, Central Street, Clerkenwell, London, EC1V 8DS, Phone: 0871 376 9004 /
+44 845 305 8304, Fax: 0871 376 9104 / +44 845 305 8343
Phone: Fax: http://www.thistle.com/en/hotels/united_kingdom/london/thistle_city_barbican/index.html
Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain
Email: Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee may
be requested if payment has not been received in full before the event. Visiongain Ltd reserves the
right to charge interest on unpaid invoices.
Signature:
Substitutions/name changes or cancellations: There is a 50% liability on all bookings once
made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or
I confirm that I have read and agree to the terms and conditions of booking after one month before the start of the event. Should you decide to cancel after this date, the full invoice
must be paid. Conference notes will then be sent to you. Unfortunately, we are unable to transfer places
Methods of payment between conferences. However, if you cannot attend the conference, you may make a substitution/name
change at any time, as long as we are informed in writing by email, fax or post. Name changes and
Payment must be made in sterling substitutions must be from the same company or organisation and are not transferable between
countries. Please note that discounted delegates places at a visiongain event are non refundable.
By Mail: Complete and return your signed registration form together with your cheque payable
Invoice alterations: There will be an administration charge of £50 for any changes to an invoice,
to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK excluding substitutions/name changes, requested by the customer. This will be charged to the
customer by credit card prior to the changes being made.
By Fax: Complete and fax your signed registration form with your credit card details
Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive
to +44 (0) 20 7549 9932 briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled
due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try
By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or
By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 expenses, which may be incurred by the customer as a consequence of the event being postponed or
cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the
By Bank Transfer: cost of the registration, travel and expenses.
Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data
Visiongain Ltd A/C: visiongain Ltd Protection Act 1988. Your personal information contained in this form may be used to update you on
Barclays Bank Sort Code: 20-71-64 visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We
may also share your data with external companies offering complementary products or services. If you
Piccadilly Branch Account No: 6038 7118 wish for your details to be amended, suppressed or not passed on to any external third party, please
48 Regent Street Swift Code: BARC GB22
send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London,
London, W1B 5RA IBAN: GB80 BARC 20716460387118 EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details.
Please allow approximately 30 days for your removal or update request to be applied to our database.
Please debit my credit card: Following your removal or update request, you may receive additional pieces of communication from
visiongain Ltd during the transitional period, whilst the changes are coming into effect.
Access MasterCard Visa American Express Fee: The conference fee includes lunch, refreshments and conference papers provided on the day.
This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly
recommend you obtain).
Card number: VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT
incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com.
Eurocash specialise in recovering cross-border VAT.
Expiry Date: How we will contact you: Visiongain Ltd’s preferred method of communication is by email and
phone. Please ensure that you complete the registration form in full so that we can contact you.
Security number (last 3 digits on back of credit card): Unable to attend
Obviously nothing compares to being there but you need not miss out. Simply tick the box and send
Signature: with your payment. You will receive speaker talks in PDFs two weeks after the event.
Yes, please send me speaker talks Price£550 VAT:£110 Total:£660
Cardholder’s name:
Office use only
News updates
Please tick if you do not want to receive email news updates in the future
www.visiongain.com/pricing-and-reimbursement